Physician profile
Lisa J Patrick
NPI 1356017446
$2,672.23
in general payments reported to CMS, 2019-2025
25 companies · $543 in 2025
The $543 reported for 2025 was more than what 88% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.13 · 2022: $142 · 2023: $1,252 · 2024: $720 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,240 · Education: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,239.87 |
| Education | $273.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $709.60 | 2023-2025 | Myfembree |
| Abbvie INC. | $578.03 | 2022-2025 | |
| Astellas Pharma US INC | $492.34 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $127.02 | 2024-2025 | Aptima, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mayne Pharma Commercial LLC | $86.39 | 2023-2025 | |
| Biogen, INC. | $80.81 | 2024-2025 | Zurzuvae |
| Organon LLC | $77.72 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $64.96 | 2024-2025 | |
| Pfizer INC. | $53.58 | 2022-2023 | |
| Daiichi Sankyo INC. | $50.93 | 2023-2024 | Injectafer |
| Exeltis, USA INC. | $43.18 | 2024-2025 | Slynd |
| Coopersurgical, INC. | $37.58 | 2023 | Paragard T 380a |
| Myovant Sciences INC. | $33.98 | 2022 | |
| Merck Sharp & Dohme LLC | $31.09 | 2023 | Gardasil 9 |
| Seqirus USA INC | $29.83 | 2025 | Flucelvax |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $27.96 | 2025 | Zepbound, Mounjaro |
| Gynesonics, INC. | $24.10 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pacira Pharmaceuticals Incorporated | $22.55 | 2024 | Exparel |
| Therapeuticsmd, INC. | $16.13 | 2021 | |
| Acella Pharmaceuticals, LLC | $14.75 | 2025 | NP Thyroid 60 |
| Convatec INC. | $14.60 | 2023 | |
| Dexcom, INC. | $14.09 | 2023 | Dexcom G6 Transmitter |
| Medtronic, INC. | $13.88 | 2024 | Truclear |
| Exact Sciences Corporation | $13.61 | 2023 | Cologuard Collection Kit |
| Pelvital USA, INC. | $13.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.